{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:50:50Z","timestamp":1790542250177,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"am","delay-in-days":670,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113948","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:24:06Z","timestamp":1635452646000},"page":"113948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1A"],"prefix":"10.1016","volume":"227","author":[{"given":"Yuka","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-5423","authenticated-orcid":false,"given":"Daichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Furuie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoe","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninako","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3464-2960","authenticated-orcid":false,"given":"Takashi","family":"Umehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7270-351X","authenticated-orcid":false,"given":"Takamitsu","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-6250","authenticated-orcid":false,"given":"Isao","family":"Kii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113948_bib1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s42003-021-02242-7","article-title":"A\u00a0human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome","volume":"4","author":"Kawatani","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2021.113948_bib2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.12688\/f1000research.27096.1","article-title":"Common genetic signatures of Alzheimer's disease in Down Syndrome","volume":"9","author":"Sharma","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.ejmech.2021.113948_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","article-title":"DYRK1A and cognition: a lifelong relationship","volume":"194","author":"Arbones","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113948_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neures.2018.09.007","article-title":"Triple play of DYRK1A kinase in cortical progenitor cells of Trisomy 21","volume":"138","author":"Kurabayashi","year":"2019","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejmech.2021.113948_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2006.11.026","article-title":"Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome","volume":"413","author":"Dowjat","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2021.113948_bib6","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/hmg\/10.18.1915","article-title":"Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome","volume":"10","author":"Altafaj","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113948_bib7","first-page":"5","article-title":"Down syndrome mouse models have an abnormal enteric nervous system","author":"Schill","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2021.113948_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2017.12.002","article-title":"Cerebellar alterations in a model of Down syndrome: the role of the Dyrk1A gene","volume":"110","author":"Garc\u00eda-Cerro","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2021.113948_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2017.06.010","article-title":"Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes","volume":"106","author":"Garc\u00eda-Cerro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2021.113948_bib10","first-page":"3822","article-title":"Overexpression of the DYRK1A gene (Dual-Specificity tyrosine phosphorylation-regulated kinase 1A) induces alterations of the serotoninergic and dopaminergic processing in murine brain tissues","volume":"55","author":"London","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2021.113948_bib11","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1523\/JNEUROSCI.2517-15.2016","article-title":"Overexpression of Dyrk1A, a down syndrome candidate, decreases excitability and impairs gamma oscillations in the prefrontal cortex","volume":"36","author":"Ruiz-Mejias","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2021.113948_bib12","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1093\/hmg\/ddv284","article-title":"Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a","volume":"24","author":"Blazek","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113948_bib13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1210\/en.2014-1329","article-title":"DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome","volume":"156","author":"Kariyawasam","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2021.113948_bib14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1523\/JNEUROSCI.2852-13.2014","article-title":"Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a","volume":"34","author":"Thomazeau","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2021.113948_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2012.01.007","article-title":"DYRK1A: a master regulatory protein controlling brain growth","volume":"46","author":"Guedj","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2021.113948_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nbd.2012.11.017","article-title":"Normalization of Dyrk1A expression by AAV2\/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome","volume":"52","author":"Altafaj","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2021.113948_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ajhg.2008.09.010","article-title":"Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome","volume":"83","author":"Ortiz-Abalia","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmech.2021.113948_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bpa.12663","article-title":"Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome","volume":"29","author":"Stagni","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejmech.2021.113948_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2017.07.026","article-title":"Neurogenesis impairment: an early developmental defect in Down syndrome","volume":"114","author":"Stagni","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113948_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature04678","article-title":"NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21","volume":"441","author":"Arron","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113948_bib21","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.066167","article-title":"Transient expression of Mnb\/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling","volume":"138","author":"H\u00e4mmerle","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.ejmech.2021.113948_bib22","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4711-09.2010","article-title":"Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells","volume":"30","author":"Yabut","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2021.113948_bib23","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4161\/cc.29104","article-title":"The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation","volume":"13","author":"Soppa","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2021.113948_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molcel.2013.09.009","article-title":"Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to control the decision to enter the cell cycle","volume":"52","author":"Chen","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2021.113948_bib25","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1073\/pnas.1704143114","article-title":"Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice","volume":"114","author":"Nakano-Kobayashi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113948_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ebiom.2015.01.010","article-title":"DYRK1A-mediated cyclin D1 degradation in neural stem cells contributes to the neurogenic cortical defects in down syndrome","volume":"2","author":"Najas","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2021.113948_bib27","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1021\/acs.jmedchem.8b00185","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors as potential therapeutics","volume":"61","author":"Jarhad","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejmech.2018.08.093","article-title":"DYRK1A kinase inhibition with emphasis on neurodegeneration: a comprehensive evolution story-cum-perspective","volume":"158","author":"Pathak","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/md15100316","article-title":"Marine-Derived 2-aminoimidazolone alkaloids. Leucettamine B-related polyandrocarpamines inhibit mammalian and Protozoan DYRK & CLK kinases","volume":"15","author":"Loa\u00ebc","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2021.113948_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/18715273113126660186","article-title":"DYRK1A: a potential drug target for multiple Down syndrome neuropathologies","volume":"13","author":"Becker","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2021.113948_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/mgg3.334","article-title":"Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits","volume":"5","author":"Stringer","year":"2017","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.ejmech.2021.113948_bib32","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1038\/s41598-019-40328-9","article-title":"Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models","volume":"9","author":"Souchet","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113948_bib33","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/s41598-018-20984-z","article-title":"DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives","volume":"8","author":"Neumann","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113948_bib34","doi-asserted-by":"crossref","first-page":"113554","DOI":"10.1016\/j.ejmech.2021.113554","article-title":"Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3\u03b2\/DYRK1A dual inhibitors for the treatment of Alzheimer's disease","volume":"222","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib35","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/acs.jmedchem.0c02050","article-title":"DYRK1A inhibitors as potential therapeutics for \u03b2-cell regeneration for diabetes","volume":"64","author":"Kumar","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9996","article-title":"GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human \u03b2 cell regeneration","volume":"12","author":"Ackeifi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2021.113948_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.cmet.2018.12.005","article-title":"Combined inhibition of DYRK1A, SMAD, and trithorax pathways synergizes to induce robust replication in adult human beta cells","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2021.113948_bib38","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1038\/ncomms9372","article-title":"Inhibition of DYRK1A and GSK3B induces human \u03b2-cell proliferation","volume":"6","author":"Shen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113948_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A\u00a0high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2021.113948_bib40","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/db15-1127","article-title":"Inhibition of DYRK1A stimulates human \u03b2-cell proliferation","volume":"65","author":"Dirice","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2021.113948_bib41","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ejmech.2018.08.007","article-title":"Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic \u03b2-cell proliferation activity","volume":"157","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cell.2005.03.034","article-title":"Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs","volume":"121","author":"Lochhead","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113948_bib43","doi-asserted-by":"crossref","first-page":"11391","DOI":"10.1038\/ncomms11391","article-title":"Selective inhibition of the kinase DYRK1A by targeting its folding process","volume":"7","author":"Kii","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113948_bib44","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1074\/jbc.271.7.3488","article-title":"Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII","volume":"271","author":"Kentrup","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj3590497","article-title":"Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A","volume":"359","author":"Himpel","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113948_bib46","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1111\/febs.12411","article-title":"Mechanism of dual specificity kinase activity of DYRK1A","volume":"280","author":"Walte","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2021.113948_bib47","first-page":"26","article-title":"Druggable transient pockets in protein kinases","author":"Umezawa","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113948_bib48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.molcel.2020.06.021","article-title":"Proline hydroxylation primes protein kinases for autophosphorylation and activation","volume":"79","author":"Lee","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2021.113948_bib49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.str.2013.03.012","article-title":"Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition","volume":"21","author":"Soundararajan","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2021.113948_bib50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","article-title":"Activation, regulation, and inhibition of DYRK1A","volume":"278","author":"Becker","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2021.113948_bib51","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2006.10.009","article-title":"A\u00a0chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation","volume":"24","author":"Lochhead","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2021.113948_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/jm201243p","article-title":"Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry","volume":"55","author":"Mendgen","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib53","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2017.1388370","article-title":"Recent developments with rhodanine as a scaffold for drug discovery","volume":"12","author":"Kaminskyy","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113948_bib54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.09.031","article-title":"5-Ene-4-thiazolidinones - an efficient tool in medicinal chemistry","volume":"140","author":"Kaminskyy","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejmech.2016.02.017","article-title":"Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2","volume":"112","author":"Mariano","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib56","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3797\/scipharm.1206-04","article-title":"Synthesis of new N,N'-Bis(5-arylidene-4-oxo-4,5-dihydrothiazolin-2-yl)piperazine derivatives under microwave irradiation and preliminary biological evaluation","volume":"80","author":"Coulibaly","year":"2012","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejmech.2021.113948_bib57","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.bbamcr.2013.02.018","article-title":"HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation","volume":"1833","author":"Siepi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113948_bib58","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014: mutations, PTMs and recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.113948_bib59","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1126\/science.aaf5023","article-title":"Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase","volume":"352","author":"Verba","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113948_bib60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.tibs.2017.07.002","article-title":"How Hsp90 and Cdc37 lubricate kinase molecular switches","volume":"42","author":"Verba","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2021.113948_bib61","doi-asserted-by":"crossref","first-page":"12728","DOI":"10.1038\/srep12728","article-title":"Identification of a DYRK1A inhibitor that induces degradation of the target kinase using Co-chaperone CDC37 fused with luciferase nanoKAZ","volume":"5","author":"Sonamoto","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113948_bib62","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cell.2012.06.047","article-title":"Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition","volume":"150","author":"Taipale","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113948_bib63","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nbt.2620","article-title":"Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells","volume":"31","author":"Taipale","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2021.113948_bib64","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.jmb.2018.05.026","article-title":"Dancing with the diva: hsp90-client interactions","volume":"430","author":"Radli","year":"2018","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113948_bib65","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41467-017-02711-w","article-title":"Phosphorylation induced cochaperone unfolding promotes kinase recruitment and client class-specific Hsp90 phosphorylation","volume":"9","author":"Bachman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113948_bib66","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pep.2009.01.010","article-title":"Expression and purification of the calcium binding photoprotein mitrocomin using ZZ-domain as a soluble partner in E. coli cells","volume":"66","author":"Inouye","year":"2009","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2021.113948_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jb\/mvx039","article-title":"A\u00a0reproducible and scalable procedure for preparing bacterial extracts for cell-free protein synthesis","volume":"162","author":"Katsura","year":"2017","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.ejmech.2021.113948_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2021.113948_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113948_bib70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1107\/S0907444909042589","article-title":"Molecular replacement with MOLREP","volume":"66","author":"Vagin","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113948_bib71","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113948_bib72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113948_bib73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113948_bib74","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1021\/ja051798v","article-title":"Functionalized higher acenes: hexacene and heptacene","volume":"127","author":"Payne","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113948_bib75","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1016\/j.tetlet.2005.10.031","article-title":"Zr-mediated hydroboration: stereoselective synthesis of vinyl boronic esters","volume":"46","author":"Wang","year":"2005","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113948_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2021.113948_bib77","author":"Stewart"},{"key":"10.1016\/j.ejmech.2021.113948_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-012-1667-x","article-title":"Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters","volume":"19","author":"Stewart","year":"2013","journal-title":"J.\u00a0Mol. Model."},{"key":"10.1016\/j.ejmech.2021.113948_bib79","doi-asserted-by":"crossref","first-page":"154102","DOI":"10.1063\/5.0005188","article-title":"Recent developments in the general atomic and molecular electronic structure system","volume":"152","author":"Barca","year":"2020","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2021.113948_bib80","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2021.113948_bib81","series-title":"Buffer systems and transfer parameters for semidry electroblotting with a horizontal apparatus","author":"Bjerrum","year":"1986"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:39:46Z","timestamp":1759329586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421007972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":81,"alternative-id":["S0223523421007972"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113948","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1A","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113948"}}